Talentum BioTech supports novel anticoagulants research. There are many sorts of Anticoagulants, but continuous optimisation is needed. Talentum BioTech supports biopharma research by means of innovative biotech/bioinformatics services. Anticoagulants is solely one type of the numerous expertises that the company has.

1. ANTICOAGULANTS

2. Anticoagulant medicines work
by interrupting part of the
process involved in the
formation of blood clots.
Blood clots are less likely to
form where they are not
needed, but can still form
when they are needed

3. Deep Vein
Trombosis
Pulmonary
Embolism
Risk of a
stroke
Atrial
Fibrillation
Risk of
developing
Blood Clots
After
Surgery
What are anticoagulants used for?

4. YEARLY EXPENSES
In 2008, 6,2 billion US Dollars
were spent on anticoagulants
In 2014, 9,1 billion US Dollars
were spent on anticoagulants
LMWH
DTI
Heparin
Factor Xa
inhibitors
Warfarin
Other
LMWH
DTI
Heparin
Factor Xa
inhibitors
Warfarin
OtherSource:
http://www.nature.com/nrd/journa
l/v8/n5/fig_tab/nrd2851_ft.html

5. Warfarin has shown to
reduce the risk of AF-
related strokes by 64%
as opposed to 19% by
Antiplatelets such as
Aspirin

6. Due to serious side-effects,
medicine optimisation is
necessary
The NOACs: Apixaban,
Dabigatronetexilate & Rivaroxaban
are the first major innovation in the
prevention of non valvular Atrial
Fibration stroke in 50 years
http://www.abpi.org.uk/our-work/library/medical-disease/Documents/ABPI%20SAFI%20report.pdf

7. Preventive stroke care will save
governments enormous amounts of
money
Continuous optimisation
safer medicines

8. Talentum BioTech offers
customized molecular simulation and
bioactive compound discovery services
to biopharma companies & academic
research groups
Talentum BioTech has experience
in the field of Anticoagulants
Click on logo to directly visit our website
(http://www.talentum-biotech.com/en/)